Form 8-K - Current report:
SEC Accession No. 0001564590-20-052718
Filing Date
2020-11-10
Accepted
2020-11-10 06:41:22
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K beam-8k_20200930.htm 8-K 32416
2 EX-99.1 beam-ex991_7.htm EX-99.1 187913
3 GRAPHIC gdanj2hyalgt000001.jpg GRAPHIC 11948
  Complete submission text file 0001564590-20-052718.txt   238046
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 201299558
SIC: 2836 Biological Products, (No Diagnostic Substances)